CDER Director Dr. Pazdur to Retire, Dr. Høeg Named as Replacement and Other CDER Leadership Changes, the U.S. House of Representatives Passes Rare Pediatric Disease Voucher Bill, and FDA’s Draft Guidance on Reducing Testing on Non-Human Primates for Monoclonal Antibodies
FDA Leaders Outline New “Plausible Mechanism Pathway,” the Agency’s Plans to Hire More Staff, and a Pilot Aimed at Faster Meeting Minutes Clarifications
Federal Court Grants Motion for Preliminary Injunction and Enforces Post-Termination Restrictive Covenants Against Signatory Franchisee and Franchisee’s Non-Signatory Employee